Marker of humoral and cellular immunity six to eight months after completing immunization against COVID-19 in residents of long-term care facilities for the elderly
- Conditions
- COVID-19U07.1COVID-19, virus identified
- Registration Number
- DRKS00025813
- Lead Sponsor
- Institut für Medizinische Virologie, Universitätsklinikum Frankfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 426
Inclusion Criteria
Complete vaccination against COVID-19 6 to 8 months at the time of inclusion in the study. No known prior infection with SARS-CoV-2. Group 1: Age 75 years or older. Resident of long-term care facility for the elderly.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive detection of anti-SARS-CoV-2 IgG and the positive detection of a SARS-CoV-2 specific T- and B-memory response.
- Secondary Outcome Measures
Name Time Method